{"id":"W4407238709","doi":"10.1038/s41408-025-01212-0","title":"The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development","year":2025,"lang":"en","type":"review","venue":"Blood Cancer Journal","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Seagen","keywords":"Medicine; Pomalidomide; Context (archaeology); Clinical trial; Multiple myeloma; Oncology; Internal medicine; Dexamethasone; Daratumumab; Clinical endpoint; Lenalidomide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003467539,0.0003876852,0.001431375,0.0007511131,0.000290519,0.00193044,0.0008141866,0.001221238,0.001696263],"category_scores_gemma":[0.004812609,0.0002729472,0.0006447291,0.0007077536,0.0009139838,0.0032291,0.0006697704,0.003528389,0.0006843813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009637098,"about_ca_system_score_gemma":0.001828904,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001037828,"about_ca_topic_score_gemma":0.002490675,"domain_scores_codex":[0.9992895,0.0003011524,0.0001293408,0.00008192367,0.0001501899,0.00004785442],"domain_scores_gemma":[0.9973775,0.00174043,0.0001837683,0.00005909513,0.0005258709,0.0001132284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003355133,0.0000914798,0.0003689455,0.01297593,0.0001494705,0.0003152135,0.0004424421,0.0009304188,0.001408552,0.01437005,0.03703339,0.9315786],"study_design_scores_gemma":[0.0001123265,0.0005650347,0.0005916716,0.008035824,0.0001608905,0.0008048766,0.000283133,0.0003704078,0.0005293086,0.01220259,0.9763072,0.00003671319],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005886199,0.9918452,0.0004289317,0.005709193,0.00045125,0.000010995,0.00002397133,0.00001460416,0.0009273251],"genre_scores_gemma":[0.006149393,0.9878523,0.0009985158,0.003610902,0.0006483385,0.00003046235,0.00003812964,0.000009496481,0.0006622727],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003467539,"threshold_uncertainty_score":0.01833832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1447630802165594,"score_gpt":0.4704130007054941,"score_spread":0.3256499204889347,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}